Leading research for life changing results
US drug company Merck has announced a $502 million acquisition of Viralytics, a virotherapy firm supported by HMRI and the University of Newcastle.
Respiratory researchers are turning to nuclear medicine for a more advanced approach to phenotyping asthma and COPD
The work of molecular nutrition researcher Dr Emma Beckett has been recognised in the 2017 NSW Young Tall Poppy awards
A world-first app will improve the rehabilitation process for patients suffering from arm impairment due to stroke
A National Partnership Forum on Indigenous Health at the HMRI Building is bringing together Australia’s leading health organisations.
Hopes of finding an early-warning signal for ovarian cancer have been boosted by a protein discovery at HMRI.
Checkpoint immune drugs like pembrolizumab (Keytruda) and nivolumab (Opdivo) are offering hope to people with cancers that were once thought untreatable
HMRI researchers have received more than $3.2 million from the NHMRC to improve outcomes for people living with dementia
A study led by the University of Newcastle (UON) received $544,096 in funding to improve the safety and outcomes of people with dementia after they are discharged from hospital
Revised clinical practice recommending a reduced antivenom dose for snakebite victims has been shown to be successful, signifying huge financial and waste savings for Australian hospitals.
A study showing a significant decline in sperm count is no cause for alarm, however lifestyle factors must still be considered.